首页 > 最新文献

Future Science OA最新文献

英文 中文
A randomized clinical trial: timing of indwelling urethral catheter removal following transurethral resection of prostate 一项随机临床试验:经尿道前列腺切除术后留置导尿管拔除的时机
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-11-10 DOI: 10.2144/fsoa-2023-0195
Saddam Al Demour, Mohammad T Al-Zubi, Mera Ababneh, Samer F Al-Rawashdah, Muayyad Ahmad
Aim: We aimed to evaluate early versus delayed removal of the indwelling urethral catheter (IUC) following transurethral resection of prostate (TURP). Methods: In this clinical trial conducted between July 2016 and June 2020, 90 patients underwent TURP were randomized equally into: group A, early IUC removal (24 h), and group B, delayed IUC removal (72 h). Results: The mean length of hospital stay was longer among the patients in group B. There were no significant differences in recatheterization, secondary bleeding, or UTI between groups A and B. The mean VAS score and CRBD were higher in group B. Conclusion: Early IUC removal following TURP is safe approach with favorable clinical outcomes. Clinical Trial Registration: NCT04363970 ( clinicaltrials.gov )
目的:我们旨在评估经尿道前列腺切除术(TURP)后早期与延迟拔除留置导尿管(IUC)的效果。方法:本临床试验于2016年7月至2020年6月进行,将90例TURP患者随机分为A组,早期IUC取出(24 h)和B组,延迟IUC取出(72 h)。结果:B组患者的平均住院时间更长,A组和B组患者在再导管、继发性出血、UTI方面无显著差异。TURP术后早期取出IUC是一种安全的方法,临床效果良好。临床试验注册:NCT04363970 (clinicaltrials.gov)
{"title":"A randomized clinical trial: timing of indwelling urethral catheter removal following transurethral resection of prostate","authors":"Saddam Al Demour, Mohammad T Al-Zubi, Mera Ababneh, Samer F Al-Rawashdah, Muayyad Ahmad","doi":"10.2144/fsoa-2023-0195","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0195","url":null,"abstract":"Aim: We aimed to evaluate early versus delayed removal of the indwelling urethral catheter (IUC) following transurethral resection of prostate (TURP). Methods: In this clinical trial conducted between July 2016 and June 2020, 90 patients underwent TURP were randomized equally into: group A, early IUC removal (24 h), and group B, delayed IUC removal (72 h). Results: The mean length of hospital stay was longer among the patients in group B. There were no significant differences in recatheterization, secondary bleeding, or UTI between groups A and B. The mean VAS score and CRBD were higher in group B. Conclusion: Early IUC removal following TURP is safe approach with favorable clinical outcomes. Clinical Trial Registration: NCT04363970 ( clinicaltrials.gov )","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":" 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135141664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Marital status impacts survival of stage I non-small-cell lung cancer: a propensity-score matching analysis 婚姻状况影响I期非小细胞肺癌的生存:倾向评分匹配分析
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-11-07 DOI: 10.2144/fsoa-2023-0103
Li-Hong Qiu, Jia-Qi Song, Feng Jiang, Yuan-Yuan Zhao, Yu'e Liu, Lei-Lei Wu, Guo-Wei Ma
Aim: This population-based analysis aimed to explore the associations among marital status, prognosis and treatment of stage I non-small-cell lung cancer. Materials & methods: The propensity score matching (PSM), logistic regression and Cox proportional hazards model were used in this study. Results: A total of 13,937 patients were included. After PSM, 10579 patients were co-insured. The married were more likely to receive surgical treatment compared with the unmarried patients (OR: 1.841, p < 0.001), and patients who underwent surgery also tended to have better survival (HR: 0.293, p < 0.001). Conclusion: Compared with unmarried patients, a married group with stage I NSCLC had timely treatment and more satisfactory survival. This study highlights the importance of prompt help and care for unmarried patients.
目的:本基于人群的分析旨在探讨婚姻状况、预后和I期非小细胞肺癌治疗之间的关系。材料,方法:采用倾向评分匹配(PSM)、logistic回归和Cox比例风险模型。结果:共纳入13937例患者。PSM后,10579名患者共保。已婚患者接受手术治疗的可能性高于未婚患者(OR: 1.841, p <0.001),接受手术的患者也倾向于有更好的生存率(HR: 0.293, p <0.001)。结论:与未婚患者相比,已婚组I期NSCLC患者治疗及时,生存更令人满意。这项研究强调了及时帮助和照顾未婚患者的重要性。
{"title":"Marital status impacts survival of stage I non-small-cell lung cancer: a propensity-score matching analysis","authors":"Li-Hong Qiu, Jia-Qi Song, Feng Jiang, Yuan-Yuan Zhao, Yu'e Liu, Lei-Lei Wu, Guo-Wei Ma","doi":"10.2144/fsoa-2023-0103","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0103","url":null,"abstract":"Aim: This population-based analysis aimed to explore the associations among marital status, prognosis and treatment of stage I non-small-cell lung cancer. Materials &amp; methods: The propensity score matching (PSM), logistic regression and Cox proportional hazards model were used in this study. Results: A total of 13,937 patients were included. After PSM, 10579 patients were co-insured. The married were more likely to receive surgical treatment compared with the unmarried patients (OR: 1.841, p < 0.001), and patients who underwent surgery also tended to have better survival (HR: 0.293, p < 0.001). Conclusion: Compared with unmarried patients, a married group with stage I NSCLC had timely treatment and more satisfactory survival. This study highlights the importance of prompt help and care for unmarried patients.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"302 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135475324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical resection due to poor outcome of the immunotherapy of a relapsed mediastinal liposarcoma: a case report 因免疫治疗效果不佳而手术切除复发性纵隔脂肪肉瘤1例
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-30 DOI: 10.2144/fsoa-2023-0099
Ming-Ji Wang, Shu-Quan Xu, Lei-Lei Wu, Zhi-Xin Li, Dong Xie
The feasibility of surgery after immunotherapy for mediastinal liposarcoma remains uncertain. Besides, the case of immunotherapy for liposarcoma is still lacking. We report a case of recurrence after resection of a left mediastinal liposarcoma. After recurrence, one course of pembrolizumab plus anlotinib hydrochloride showed no tumor shrinkage, and genetic testing showed CDK4 amplification and PD-L1 TPS <1%; therefore, the plan was changed to one course of pembrolizumab plus palbociclib, but the tumor still did not shrink. Thus, second tumor resection was performed. In addition, the postoperative pathology was still well-differentiated liposarcoma. The significance of immunotherapy in liposarcoma still needs to be further explored. In the absence of surgical contraindications, secondary surgery might be feasible.
纵隔脂肪肉瘤免疫治疗后手术的可行性仍不确定。此外,脂肪肉瘤的免疫治疗案例仍然缺乏。我们报告一个左纵隔脂肪肉瘤切除后复发的病例。复发后,派姆单抗联合盐酸安洛替尼1个疗程未见肿瘤缩小,基因检测显示CDK4扩增,PD-L1 TPS <1%;因此,计划改为派姆单抗加帕博西尼一个疗程,但肿瘤仍然没有缩小。因此,进行第二次肿瘤切除术。术后病理仍为高分化脂肪肉瘤。免疫治疗在脂肪肉瘤中的意义还有待进一步探讨。在没有手术禁忌的情况下,二次手术可能是可行的。
{"title":"Surgical resection due to poor outcome of the immunotherapy of a relapsed mediastinal liposarcoma: a case report","authors":"Ming-Ji Wang, Shu-Quan Xu, Lei-Lei Wu, Zhi-Xin Li, Dong Xie","doi":"10.2144/fsoa-2023-0099","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0099","url":null,"abstract":"The feasibility of surgery after immunotherapy for mediastinal liposarcoma remains uncertain. Besides, the case of immunotherapy for liposarcoma is still lacking. We report a case of recurrence after resection of a left mediastinal liposarcoma. After recurrence, one course of pembrolizumab plus anlotinib hydrochloride showed no tumor shrinkage, and genetic testing showed CDK4 amplification and PD-L1 TPS <1%; therefore, the plan was changed to one course of pembrolizumab plus palbociclib, but the tumor still did not shrink. Thus, second tumor resection was performed. In addition, the postoperative pathology was still well-differentiated liposarcoma. The significance of immunotherapy in liposarcoma still needs to be further explored. In the absence of surgical contraindications, secondary surgery might be feasible.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"133 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136104083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology 棘囊酸在阿尔茨海默病样病理中的作用的计算机和药代动力学评价
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-04 DOI: 10.2144/fsoa-2023-0150
Ankul Singh S, Chitra Vellapandian
Aim: Alzheimer's disease causes dementia which impairs the cognitive domains. Methodology: The pharmacokinetic characteristics and biological activity of echinocystic acid are predicted in this work using in silico or computational approaches, including pkCSM, Swiss ADME, OSIRIS ® property explorer, PASS online web resource and MOLINSPIRATION ® software. Results & discussion: The compound has lipid metabolism regulating property as major role in decreasing the progression of Alzheimer's disease and it has no major side effects and ADR. The drug also has anti-inflammatory properties which can help in regulating the innate immunity that plays a major role in Alzheimer's disease. Conclusion: From the computational screening, we infer that, echinocystic acid can regulate memory loss, cognitive disability and also slow down the progression of Alzheimer's disease-like pathology.
目的:阿尔茨海默病导致痴呆,损害认知领域。方法:采用计算机或计算方法,包括pkCSM、Swiss ADME、OSIRIS®属性浏览器、PASS在线网络资源和MOLINSPIRATION®软件,预测棘囊酸的药代动力学特性和生物活性。结果,讨论:该化合物具有调节脂质代谢的特性,在减缓阿尔茨海默病的进展中起主要作用,且无重大副作用和不良反应。该药还具有抗炎特性,可以帮助调节先天免疫,而先天免疫在阿尔茨海默病中起着重要作用。结论:通过计算筛选,我们推断棘囊酸可以调节记忆丧失、认知功能障碍,并减缓阿尔茨海默病样病理进展。
{"title":"<i>In silico</i> and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology","authors":"Ankul Singh S, Chitra Vellapandian","doi":"10.2144/fsoa-2023-0150","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0150","url":null,"abstract":"Aim: Alzheimer's disease causes dementia which impairs the cognitive domains. Methodology: The pharmacokinetic characteristics and biological activity of echinocystic acid are predicted in this work using in silico or computational approaches, including pkCSM, Swiss ADME, OSIRIS ® property explorer, PASS online web resource and MOLINSPIRATION ® software. Results &amp; discussion: The compound has lipid metabolism regulating property as major role in decreasing the progression of Alzheimer's disease and it has no major side effects and ADR. The drug also has anti-inflammatory properties which can help in regulating the innate immunity that plays a major role in Alzheimer's disease. Conclusion: From the computational screening, we infer that, echinocystic acid can regulate memory loss, cognitive disability and also slow down the progression of Alzheimer's disease-like pathology.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"99 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135592092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis FOXD1在各种癌症中的预后和临床病理意义:meta和生物信息分析
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-09-07 DOI: 10.2144/fsoa-2023-0085
Xiaohan Liu, Shengyun Min, Qin Zhang, Yan Liu, Zhenhong Zou, Nanye Wang, Bin Zhou
Aim: To examine both predictive and clinicopathological importance underlying FOXD1 in malignant tumors, our study adopts meta-analysis. Methods: We searched from PubMed, Embase, WOS, Wanfang and CNKI. Stata SE15.1 was used to calculate the risk ratio (HR) as well as relative risk (RR) with 95% of overall confidence intervals (CIs) to assess FOXD1 and overall survival rate (OS), disease-free survival rate ( FOXD1) as well as clinicopathological parameters. Results: 3808 individuals throughout 17 trials showed high FOXD1 expression was linked to disadvantaged OS (p < 0.001) and disease-free survival (p < 0.001) and higher TNM stage (p < 0.001). Conclusion: Elevated FOXD1 had worse predictions and clinicopathological parameters in most cancers. The GEPIA database findings also support our results.
目的:为了研究FOXD1在恶性肿瘤中的预测和临床病理意义,本研究采用荟萃分析。方法:检索PubMed、Embase、WOS、万方、中国知网。采用Stata SE15.1计算95%的总置信区间(ci)的风险比(HR)和相对风险(RR),评估FOXD1和总生存率(OS)、无病生存率(FOXD1)以及临床病理参数。结果:17项试验中的3808例个体显示FOXD1高表达与不利OS相关(p <0.001)和无病生存率(p <0.001)和更高的TNM分期(p <0.001)。结论:FOXD1升高在大多数癌症中具有较差的预后和临床病理参数。GEPIA数据库的发现也支持我们的结果。
{"title":"Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis","authors":"Xiaohan Liu, Shengyun Min, Qin Zhang, Yan Liu, Zhenhong Zou, Nanye Wang, Bin Zhou","doi":"10.2144/fsoa-2023-0085","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0085","url":null,"abstract":"Aim: To examine both predictive and clinicopathological importance underlying FOXD1 in malignant tumors, our study adopts meta-analysis. Methods: We searched from PubMed, Embase, WOS, Wanfang and CNKI. Stata SE15.1 was used to calculate the risk ratio (HR) as well as relative risk (RR) with 95% of overall confidence intervals (CIs) to assess FOXD1 and overall survival rate (OS), disease-free survival rate ( FOXD1) as well as clinicopathological parameters. Results: 3808 individuals throughout 17 trials showed high FOXD1 expression was linked to disadvantaged OS (p < 0.001) and disease-free survival (p < 0.001) and higher TNM stage (p < 0.001). Conclusion: Elevated FOXD1 had worse predictions and clinicopathological parameters in most cancers. The GEPIA database findings also support our results.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135047708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of cellular environment on in vitro drug screening. 细胞环境对体外药物筛选的影响。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-09-07 eCollection Date: 2023-10-01 DOI: 10.2144/fsoa-2023-0027
Aiman Moldasheva, Laura Bakyt, Denis Bulanin, Mohamad Aljofan

There are various reasons for drug failure in the developmental stage including toxicity, adverse effects and inefficacy. This is likely due to the differences in drug behavior between a simple and controlled cell culture system to that of a more complex whole organism environment. While the use of human phenotypical cells relevant to the condition may provide more accurate screening results, they are susceptible to producing false positives as cells are continuously influenced by constant chemical and physical interaction with the surrounding microenvironment. Therefore, several microenvironmental and pharmacomechanical aspects must be factored in during tissue culture drug screening.

药物在发育阶段失败的原因多种多样,包括毒性、不良反应和无效。这可能是由于简单和受控的细胞培养系统与更复杂的整个生物体环境在药物行为上的差异。虽然使用与该条件相关的人类表型细胞可以提供更准确的筛选结果,但它们容易产生假阳性,因为细胞不断受到与周围微环境的化学和物理相互作用的影响。因此,在组织培养药物筛选过程中,必须考虑几个微环境和药物力学方面。
{"title":"The impact of cellular environment on <i>in vitro</i> drug screening.","authors":"Aiman Moldasheva,&nbsp;Laura Bakyt,&nbsp;Denis Bulanin,&nbsp;Mohamad Aljofan","doi":"10.2144/fsoa-2023-0027","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0027","url":null,"abstract":"<p><p>There are various reasons for drug failure in the developmental stage including toxicity, adverse effects and inefficacy. This is likely due to the differences in drug behavior between a simple and controlled cell culture system to that of a more complex whole organism environment. While the use of human phenotypical cells relevant to the condition may provide more accurate screening results, they are susceptible to producing false positives as cells are continuously influenced by constant chemical and physical interaction with the surrounding microenvironment. Therefore, several microenvironmental and pharmacomechanical aspects must be factored in during tissue culture drug screening.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 9","pages":"FSO900"},"PeriodicalIF":2.5,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41178508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The increasing importance of the oral microbiome in periodontal health and disease. 口腔微生物群在牙周健康和疾病中的重要性日益增加。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-09-01 DOI: 10.2144/fsoa-2023-0062
Ruqaiyyah Siddiqui, Zahi Badran, Anania Boghossian, Ahmad M Alharbi, Hasan Alfahemi, Naveed Ahmed Khan

Herein, the aim is to discuss the current knowledge of microbiome and periodontal diseases. Current treatment strategies include mechanical therapy such as root planing, scaling, deep pocket debridement and antimicrobial chemotherapy as an adjuvant therapy. Among promising therapeutic strategies, dental probiotics and oral microbiome transplantation have gained attention, and may be used to treat bacterial imbalances by competing with pathogenic bacteria for nutrients and adhesion surfaces, as well as probiotics targeting the gut microbiome. Development of strategies to prevent and treat periodontal diseases are warranted as both are highly prevalent and can affect human health. Further studies are necessary to better comprehend the microbiome in order to develop innovative preventative measures as well as efficacious therapies against periodontal diseases.

在这里,目的是讨论微生物组和牙周病的当前知识。目前的治疗策略包括机械治疗,如根刨、刮治、深袋清创和抗菌化疗作为辅助治疗。在有前景的治疗策略中,口腔益生菌和口腔微生物组移植受到了关注,它们可能通过与致病菌竞争营养和粘附表面来治疗细菌失衡,以及针对肠道微生物组的益生菌。制定预防和治疗牙周病的战略是必要的,因为这两种疾病都非常普遍,并可能影响人类健康。进一步的研究是必要的,以便更好地了解微生物组,以制定创新的预防措施以及有效的治疗牙周病。
{"title":"The increasing importance of the oral microbiome in periodontal health and disease.","authors":"Ruqaiyyah Siddiqui,&nbsp;Zahi Badran,&nbsp;Anania Boghossian,&nbsp;Ahmad M Alharbi,&nbsp;Hasan Alfahemi,&nbsp;Naveed Ahmed Khan","doi":"10.2144/fsoa-2023-0062","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0062","url":null,"abstract":"<p><p>Herein, the aim is to discuss the current knowledge of microbiome and periodontal diseases. Current treatment strategies include mechanical therapy such as root planing, scaling, deep pocket debridement and antimicrobial chemotherapy as an adjuvant therapy. Among promising therapeutic strategies, dental probiotics and oral microbiome transplantation have gained attention, and may be used to treat bacterial imbalances by competing with pathogenic bacteria for nutrients and adhesion surfaces, as well as probiotics targeting the gut microbiome. Development of strategies to prevent and treat periodontal diseases are warranted as both are highly prevalent and can affect human health. Further studies are necessary to better comprehend the microbiome in order to develop innovative preventative measures as well as efficacious therapies against periodontal diseases.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 8","pages":"FSO856"},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10069743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required? 人造甜味剂对代谢综合征的威胁越来越大:为什么需要额外的关注?
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-09-01 DOI: 10.2144/fsoa-2023-0092
Sarvesh Sabarathinam, Dhivya Dhanasekaran, Nila Ganamurali
Sarvesh Sabarathinam*,‡ ,1,2,3 , Dhivya Dhanasekaran‡ ,3 & Nila Ganamurali‡ ,3 1Drug testing Laboratory, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India 2Clinical Trial Unit, Metabolic Ward, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India 3Certificate Program-Analytical Techniques in Herbal Drug Industry, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India *Author for correspondence: sarveshtvg@gmail.com ‡Authors contributed equally
{"title":"Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?","authors":"Sarvesh Sabarathinam,&nbsp;Dhivya Dhanasekaran,&nbsp;Nila Ganamurali","doi":"10.2144/fsoa-2023-0092","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0092","url":null,"abstract":"Sarvesh Sabarathinam*,‡ ,1,2,3 , Dhivya Dhanasekaran‡ ,3 & Nila Ganamurali‡ ,3 1Drug testing Laboratory, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India 2Clinical Trial Unit, Metabolic Ward, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India 3Certificate Program-Analytical Techniques in Herbal Drug Industry, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India *Author for correspondence: sarveshtvg@gmail.com ‡Authors contributed equally","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 8","pages":"FSO880"},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10075671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human herpesvirus-7 meningitis in an immunocompetent adult patient: a case report. 人疱疹病毒-7型脑膜炎1例免疫功能正常的成人患者:1例报告。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-09-01 DOI: 10.2144/fsoa-2023-0021
Rabih Fares, Madonna Matar

Aim: The underlying pathological mechanisms of CNS human herpesvirus-7 (HHV-7) related infections are still unknown, especially among immunocompetent adults. Although HHV-7 meningitis in immunocompetent adults is usually uncommon, serious consideration for possible HHV-7 involvement should be taken when assessing CNS infection of unknown etiology.

Case presentation: We report a 53-year-old female who presented for fever and progressive headaches. Cerebrospinal fluid (CSF) analysis was compatible with a viral meningitis. CSF cultures were negative and HHV-7 DNA was the only strain detected in the CSF analysis. The patient died 1 month later following complications and cardiac arrest.

Conclusion: HHV-7 CNS infection in immunocompetent patient can be a serious infection. Prompt diagnosis and treatment management are essential for better outcome.

目的:中枢神经系统人类疱疹病毒-7 (HHV-7)相关感染的潜在病理机制尚不清楚,特别是在免疫功能正常的成年人中。虽然HHV-7脑膜炎在免疫功能正常的成年人中通常不常见,但在评估病因不明的中枢神经系统感染时,应认真考虑可能涉及HHV-7。病例介绍:我们报告一位53岁的女性,她表现为发烧和进行性头痛。脑脊液(CSF)分析与病毒性脑膜炎相符。脑脊液培养阴性,HHV-7 DNA是脑脊液分析中唯一检测到的菌株。患者1个月后死于并发症和心脏骤停。结论:免疫功能正常患者的HHV-7中枢神经系统感染可为严重感染。及时的诊断和治疗管理对改善预后至关重要。
{"title":"Human herpesvirus-7 meningitis in an immunocompetent adult patient: a case report.","authors":"Rabih Fares,&nbsp;Madonna Matar","doi":"10.2144/fsoa-2023-0021","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0021","url":null,"abstract":"<p><strong>Aim: </strong>The underlying pathological mechanisms of CNS human herpesvirus-7 (HHV-7) related infections are still unknown, especially among immunocompetent adults. Although HHV-7 meningitis in immunocompetent adults is usually uncommon, serious consideration for possible HHV-7 involvement should be taken when assessing CNS infection of unknown etiology.</p><p><strong>Case presentation: </strong>We report a 53-year-old female who presented for fever and progressive headaches. Cerebrospinal fluid (CSF) analysis was compatible with a viral meningitis. CSF cultures were negative and HHV-7 DNA was the only strain detected in the CSF analysis. The patient died 1 month later following complications and cardiac arrest.</p><p><strong>Conclusion: </strong>HHV-7 CNS infection in immunocompetent patient can be a serious infection. Prompt diagnosis and treatment management are essential for better outcome.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 8","pages":"FSO876"},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10074092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Establishment of cancer cell line originating from a patient with high-grade serous ovarian carcinoma. 高级别浆液性卵巢癌患者癌细胞系的建立。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-09-01 DOI: 10.2144/fsoa-2023-0025
Nguyen Thuy Linh, Ngo Thu Hang, Bui Khac Cuong, Dang Thuy Linh, Nham Thi Phuong Linh, Do Nguyen-Van, Tran Ngoc Dzung, Can Van Mao, Dang Thanh Chung, Le Tri Chinh, Nguyen Phu Hung, Hoang Van Tong, Nguyen Linh Toan

Aim: Ovarian cancer is a serious malignancy with high prevalence and mortality.

Methods: We isolated and characterized an ovarian high-grade serous cancer cell line (M4) from a tumor of a Vietnamese patient with ovarian carcinoma.

Results: The M4 cancer cell line showed good proliferation and stability in culture. Morphologically, the M4 cells showed similar characteristics to tumor cells such as a polyhedral shape, large irregular nuclei, high nuclear/cytoplasmic ratio, high nuclear density and expressing cancer markers like CA125, p53 and Ki67 markers.

Conclusion: We have successfully isolated and characterized the M4 cell line from a Vietnamese patient with ovarian carcinoma.

目的:卵巢癌是一种发病率高、死亡率高的恶性肿瘤。方法:我们从一名越南卵巢癌患者的肿瘤中分离并鉴定了一株卵巢高级别浆液性癌细胞(M4)。结果:M4癌细胞在培养中表现出良好的增殖和稳定性。形态学上,M4细胞表现出与肿瘤细胞相似的多面体形状,细胞核大而不规则,核质比高,核密度高,表达CA125、p53、Ki67等肿瘤标志物。结论:我们成功分离并鉴定了一例越南卵巢癌患者的M4细胞系。
{"title":"Establishment of cancer cell line originating from a patient with high-grade serous ovarian carcinoma.","authors":"Nguyen Thuy Linh,&nbsp;Ngo Thu Hang,&nbsp;Bui Khac Cuong,&nbsp;Dang Thuy Linh,&nbsp;Nham Thi Phuong Linh,&nbsp;Do Nguyen-Van,&nbsp;Tran Ngoc Dzung,&nbsp;Can Van Mao,&nbsp;Dang Thanh Chung,&nbsp;Le Tri Chinh,&nbsp;Nguyen Phu Hung,&nbsp;Hoang Van Tong,&nbsp;Nguyen Linh Toan","doi":"10.2144/fsoa-2023-0025","DOIUrl":"https://doi.org/10.2144/fsoa-2023-0025","url":null,"abstract":"<p><strong>Aim: </strong>Ovarian cancer is a serious malignancy with high prevalence and mortality.</p><p><strong>Methods: </strong>We isolated and characterized an ovarian high-grade serous cancer cell line (M4) from a tumor of a Vietnamese patient with ovarian carcinoma.</p><p><strong>Results: </strong>The M4 cancer cell line showed good proliferation and stability in culture. Morphologically, the M4 cells showed similar characteristics to tumor cells such as a polyhedral shape, large irregular nuclei, high nuclear/cytoplasmic ratio, high nuclear density and expressing cancer markers like CA125, p53 and Ki67 markers.</p><p><strong>Conclusion: </strong>We have successfully isolated and characterized the M4 cell line from a Vietnamese patient with ovarian carcinoma.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 8","pages":"FSO875"},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10075669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future Science OA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1